Alumni Ventures

Alumni Ventures Group, LLC is a venture capital firm founded in 2013 and based in Manchester, New Hampshire, with additional offices in major cities across North America. The firm specializes in seed, early-stage, and late-stage pre-IPO investments, focusing on companies with an alumni connection and supported by established institutional lead investors. Alumni Ventures aims to provide accredited investors, particularly alumni from top entrepreneurial schools, with access to diversified venture portfolios that span various sectors and geographic regions. The firm typically invests between $0.01 million and $3 million and does not require board or observer seats in its portfolio companies. Through its managed fund families, Alumni Ventures enables investors to participate in a collaborative investment approach, fostering connections among alumni while facilitating investment opportunities in innovative ventures.

Rob Adams

Managing Partner

Gail Ball

Venture Scout

Andrew Baum

Vice President, Treasury and Capital Management

David Beazley

Executive Partner

Ali Byrd

Investor Advisory Council Member

Matt Caspari

Managing Partner, Strawberry Creek and amp; Deep Tech

Matt Castellini

Senior Associate

Helen Chen

CEO Services Analyst

Cainon Coates

Managing Partner

Michael Collins

CEO

Thomas Edwards

Associate

Yev Gelfand

Investor

Mason Hale

Senior Associate, Chestnut Street and Triphammer Ven

Jin Kim

Senior Vice President, Office of Investments

Lucas Kirshenbaum

VC Investor

Ron Levin

Managing Partner, AV Seed Fund and Doctors Innovate Fund

Jess Liu-Brown

Principal

Michael Madden

Co-Founder and Investment Professionals

Jonathan Meltzer

Managing Partner

Tom Meyer

Managing Partner, Nassau Street

Keith Murphy

Director, Video Programs

David Muson

CFO

Aisha Robinson

Comms Team VP of Strategic Communications

Saad Shaheen

Investor Operations Manager

Stephen Stolzenberg

Senior Associate

Justin Strausbaugh

Managing Partner, Lakeshore

Brittney Wade

Senior Associate, Seed Fund

Sarah Worden

Venture Scout

Wesley Yiu

Partner

Henri Yuan

Investor

Michael Yuann

Director of Investment Operations

Past deals in Portland, OR

Boulder Care

Series B in 2022
Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.

Conversa

Series B in 2021
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.

Eclypsium

Series B in 2020
Eclypsium, Inc. is a cybersecurity company based in Portland, Oregon, founded in 2017. It specializes in a cloud-based device security platform designed to protect the firmware and hardware layers of enterprise infrastructure, which includes laptops, servers, and networking equipment. The platform enables security teams to gain insights into vulnerabilities below the operating system, allowing for the implementation of essential security controls. Additionally, Eclypsium focuses on digital supply chain security, ensuring the integrity of critical software, firmware, and hardware within organizations. By addressing risks associated with complex technology supply chains, Eclypsium aims to enhance the overall security posture of enterprises and government agencies.

Eclypsium

Convertible Note in 2020
Eclypsium, Inc. is a cybersecurity company based in Portland, Oregon, founded in 2017. It specializes in a cloud-based device security platform designed to protect the firmware and hardware layers of enterprise infrastructure, which includes laptops, servers, and networking equipment. The platform enables security teams to gain insights into vulnerabilities below the operating system, allowing for the implementation of essential security controls. Additionally, Eclypsium focuses on digital supply chain security, ensuring the integrity of critical software, firmware, and hardware within organizations. By addressing risks associated with complex technology supply chains, Eclypsium aims to enhance the overall security posture of enterprises and government agencies.

Conversa

Venture Round in 2020
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.

Conversa

Series B in 2020
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.

Brave Care

Seed Round in 2019
Brave Care, Inc. is a healthcare provider specializing in urgent pediatric services. Founded in 2017 and based in Portland, Oregon, the company operates clinics that address a variety of childhood illnesses and injuries. Services offered include treatment for allergies, asthma, coughs, ear pain, eye problems, fever, and urinary tract infections. Brave Care also provides care for minor fractures, strains, sprains, and head trauma, along with pediatric-specific laboratory services and on-site x-ray capabilities. The clinics are equipped to perform procedures such as stitches and tissue glue application for wound closure, as well as mild sedation for uncomfortable treatments.

SHIFT

Series C in 2017
Shift Technologies, Inc. operates an online platform that facilitates the buying and selling of new and used cars, offering a range of vehicle types including sedans, SUVs, and trucks. Founded in 2013 and headquartered in San Francisco, California, with additional locations in Los Angeles, San Diego, Sacramento, and Portland, Shift aims to simplify the car purchase experience. The company provides a comprehensive service that includes detailing vehicles, listing them on multiple platforms, managing test drives, and connecting sellers with potential buyers. Customers receive a detailed 150-point concierge report that encompasses vehicle specifications, high-resolution images, and history reports. Shift also offers financing options and additional support services throughout the car ownership lifecycle, making the process more accessible and enjoyable for consumers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.